PFPT
TAK icon

Pinnacle Financial Partners (Tennessee)’s Takeda Pharmaceutical TAK Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-176
Closed -$3K – 474
2019
Q4 		$3K Buy
+176
New +$3.37K ﹤0.01% 455
2019
Q2 		– Sell
-357
Closed -$7K – 453
2019
Q1 		$7K Buy
+357
New +$7.18K ﹤0.01% 406

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s TAK Position: Q1 2020 in Review

Pinnacle Financial Partners (Tennessee) sold out of Takeda Pharmaceutical (TAK) in Q1 2020, closing a stake of 176 shares — an estimated $3K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in TAK in Q1 2019 and held it in 2 quarters. The position peaked at $7K in Q1 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2020.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Takeda Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 176 Takeda Pharmaceutical shares in Q1 2020, an estimated $3K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 2 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Takeda Pharmaceutical position peaked at $7K in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2020.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q1 2020, filed 16 Apr 2020.